Small molecule neurolysin activators, potential multi-mechanism agents for ischemic stroke therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Small molecule neurolysin activators, potential multi-mechanism agents for ischemic stroke therapy

Published:2022-05-04 Issue:5 Volume:26 Page:401-404
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Esfahani Shiva Hadi¹,Abbruscato Thomas J.¹²,Trippier Paul C.³,Karamyan Vardan T.¹²^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX, USA

2. Center for Blood Brain Barrier Research, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA

3. Center for Drug Discovery, University of Nebraska Medical Center, Omaha, NE, USA

Funder

laboratory focusing on small molecule Nln activators

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2022.2077190

Reference17 articles.

1. Stroke research at a crossroad: asking the brain for directions

2. Peptidase neurolysin is an endogenous cerebroprotective mechanism in acute neurodegenerative disorders

3. Neurolysin: From Initial Detection to Latest Advances

4. Functional up-regulation of endopeptidase neurolysin during post-acute and early recovery phases of experimental stroke in mouse brain

5. Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural basis of divergent substrate recognition and inhibition of human neurolysin;Scientific Reports;2024-08-08

2. Imidazole Bioisostere Activators of Endopeptidase Neurolysin with Enhanced Potency and Metabolic Stability;ACS Medicinal Chemistry Letters;2024-03-29

3. Discovery of the Next Generation of Non-peptidomimetic Neurolysin Activators with High Blood-Brain Barrier Permeability: a Pharmacokinetics Study in Healthy and Stroke Animals;Pharmaceutical Research;2023-10-13

4. Kaempferol as a therapeutic agent in Alzheimer’s disease: Evidence from preclinical studies;Ageing Research Reviews;2023-06

5. The evolution of small molecule enzyme activators;RSC Medicinal Chemistry;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3